RecallDepth
Class II Terminated

Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4175-73, b) 200 mL bottle when mixed, NDC 0093-4175-74, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.

Company
Teva Pharmaceuticals Usa
Recall Initiated
August 24, 2020
Posted
September 16, 2020
Recall Number
D-0012-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
103,940 bottles
Firm Location
Parsippany, NJ, United States

Reason for Recall

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Distribution

Nationwide in the U.S. and Puerto Rico.

Lot / Code Info

Lot #s: a) 30309820A, Exp. 08/2020; 30310000B, 30310001B, Exp. 10/2020; 30310096A Exp. 01/2021; 30310228A, Exp. 03/2021; 30310313A, Exp. 06/2021; b) 30309861A, Exp. 08/2020; 30310335A, Exp. 06/2021.

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls